Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research pipeline.
Soins de santé et hôpitaux, Santé
2026-04-28 8:30 AM EDT | Adia Nutrition Inc.
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada's Digital Marketplace
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap Foods"), has secured a listing on Walmart Canada's online marketplace, Walmart.ca. The Company's initial product lineup has been accepted for sale, with inventory currently in transit to Walmart's fulfillment network. Product availability
Technologies, Biotechnologies, Santé
2026-04-28 8:00 AM EDT | Restart Life Sciences Corp.
Edison Issues Report on Halyk Bank (HSBK)
London, United Kingdom--(Newsfile Corp. - April 28, 2026) - Edison issues report on Halyk Bank (LSE: HSBK). Halyk Bank offers a combination of an ROE in excess of 30%, a leading market position (close to 30% of total assets of Kazakhstan's commercial banking sector), solid cost discipline (cost-to-income ratio below 20%), continued focus on expanding its digital ecosystem (with encouraging growth in user engagement lately) and a sound capital base. The company, therefore, represents a q
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-04-28 7:36 AM EDT | Edison Group
WELL Health to Announce First Quarter 2026 Financial Results on May 7, 2026
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal First Quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursd
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-04-28 7:00 AM EDT | WELL Health Technologies Corp.
Tersis Technologies Executes MOU for First UK Oaktree Modular Waste-to-Energy Deployment
Brooksville, Florida--(Newsfile Corp. - April 27, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a circular economy infrastructure company focused on converting waste into energy and high-value byproducts, today announced that it has executed a non-binding Memorandum of Understanding ("MOU") with Vivum Intelligent Media Limited ("Vivum") to pursue the first United Kingdom deployment of Tersis' Oaktree modular utility platform. The collaboration is focused o
Agriculture, Énergie, Énergies de substitution, Santé
2026-04-27 10:46 AM EDT | Tersis Technologies Inc.
Edison Issues Report on PWO Group (PWO)
London, United Kingdom--(Newsfile Corp. - April 27, 2026) - Edison issues report on PWO Group (XETRA: PWO). PWO's FY25 results confirmed the preliminary figures, which slightly exceeded our expectations but still reflected declines in revenues and EBITDA. A positive surprise was the far better level of new business: €760m with a very strong €225m in Q4. The weak outlook for automotive in the short term, the geopolitical unrest and a shift of production from Germany to Easter
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-04-27 9:05 AM EDT | Edison Group
Senior Care Authority Highlights the Growing Strain on Families Caring for Loved Ones Across Generations as Mother's Day Approaches
Incline Village, Nevada--(Newsfile Corp. - April 27, 2026) - As families gather for Mother's Day, experts say the holiday is about more than celebration. It is often one of the few times each year when adult children spend extended, in-person time with their aging parents, making it a critical moment to notice changes that may otherwise go unseen. Senior Care Authority, a nationally recognized leader in eldercare consulting
Soins de santé et hôpitaux, Santé
2026-04-27 8:00 AM EDT | Senior Care Authority
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce that, further to their joint press release dated March 10, 2026 and March 23, 2026, Filament's shareholders (the "Filament Shareholders") have approved each of the matters voted on at the Filament annual general and special meeting ("Filament Meeting") hel
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-27 7:30 AM EDT | Red Light Holland Corp.
QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths
Patent-protected QAI Platform identifies the probable drug class - alcohol, opioids, benzodiazepines, stimulants, or cannabis from physiological camera data and simultaneously administers CIWA-Ar, COWS, C-SSRS and 10 further validated clinical instruments in under seven minutes with no hardware and no IT project; former Director of Pentagon Joint Artificial Intelligence Center advancing commercial engagement across US correctional facilities and national defense installations; Canadian cor
2026-04-27 6:53 AM EDT | QScreen AI Inc.
Defence Therapeutics Announces Grant of Restricted Stock Units
Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of the Company approved the grant of 200,000 incentive restricted stock units ("RSUs") to Mr. Sebastien Plouffe, CEO and Director of the Company, vesting immediately. Each RSU entitles the
Biotechnologies, Pharmaceutique, Santé
2026-04-24 6:30 PM EDT | Defence Therapeutics Inc.
UberDoc Health Technologies Corp. Announces Board Transition as Jeffrey Hogan Focuses on The Judi Group
Boston, Massachusetts--(Newsfile Corp. - April 24, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0), the direct-pay healthcare marketplace for specialty care, today announced that Jeffrey Hogan has stepped down from its Board of Directors. Hogan will focus his attention on the Judi Group, the healthcare advisory firm he co-founded in January 2026 to address fiduciary compliance and cost transparency in employer-sponsored health plans. Hogan brought more than four de
2026-04-24 5:00 PM EDT | UberDoc
MyndTec Inc. Makes Voluntary Assignment in Bankruptcy Under the Bankruptcy and Insolvency Act (Canada)
Mississauga, Ontario--(Newsfile Corp. - April 24, 2026) - Further to its press release dated April 8, 2026, MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company") announced today that, having been unable to secure the additional financing required to continue operations, it has made a voluntary assignment in bankruptcy for the general benefit of its creditors pursuant to section 49 of the Bankruptcy and Insolvency Act (Canada) (the "BIA"). After care
Technologies, Soins de santé et hôpitaux, Santé
2026-04-24 4:41 PM EDT | MyndTec Inc.
Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to announce the completion of its previously announced qualifying transaction (the "Qualifying Transaction") under Policy 2.4 - Capital Pool Companies of the TSX Venture Exchange (the "TSXV"). Trading of the shares of the Company is expected to resume on the TSXV on
2026-04-24 1:02 PM EDT | Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.)
Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW
Singapore, Singapore--(Newsfile Corp. - April 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company") today announced that it has secured an additional 35 megawatts (MW) of high-density artificial intelligence (AI) data centre capacity through its subsidiary PP GRID SDN. BHD. (PPG). With this latest acquisition, a total of 60MW of AI data centre capacity is now secured under the PPG platform. This newly secured 35MW
2026-04-24 9:32 AM EDT | Mobile-health Network Solutions
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and execution of clinical supply shipments of PEX010, a botanical psilocybin drug candidate developed by Filament Health Corp., to leading Canadian research institutions. Following its press release dated April 7, 2026, Red Light is highlighting recent accomplishments and ongoing momentum, including
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-24 8:26 AM EDT | Red Light Holland Corp.
Core Progression Elite Personal Training and Vitelize Health Launch Colorado's First Gym-Integrated GLP-1 Weight-Loss Program
Denver, Colorado--(Newsfile Corp. - April 23, 2026) - Core Progression Elite Personal Training ("Core Progression") and Vitelize Health ("Vitelize") have launched a coordinated GLP-1 weight-loss model that places independent, physician-directed clinics inside Core Progression studios. Vitelize operates on-site clinics at two Denver-metro locations, with program access available to members and clients across all Core Progression De
2026-04-23 7:44 PM EDT | Vitelize Health
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has surpassed 500,000 units sold from January 2023 through March 2026. This milestone reflects continued consumer adoption, repeat purchasing behavior, and steady brand development within the "better-for-you" food category. The C
Technologies, Biotechnologies, Santé
2026-04-23 8:00 AM EDT | Restart Life Sciences Corp.
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, today highlights recent U.S. federal policy developments supporting psychedelic research and outlines the potential implications for the sector and the Company. Recent announcements by U.S. President Donald Trump include an exec
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-04-23 7:30 AM EDT | Psyched Wellness Ltd.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities,
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that further to its press release dated March 16, 2026, it intends to complete a portion of its previously announced offering of common shares (the "Offering") in Canada pursuant to the Listed Issuer Financing Exemption c
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-23 7:00 AM EDT | Optimi Health Corp.